Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Bernstein

Showing results (41-50 of 379) with videos related to

Pageof 38
Sort By:
JAMA|May 2, 2013
HPV vaccination: too soon for 2 doses?Jessica A Kahn, David I Bernstein
Allergy and Asthma Proceedings|July 12, 2022
Safety of subcutaneous allergen immunotherapyDavid I Bernstein, Tolly G Epstein
The Journal of Allergy and Clinical Immunology. in Practice|May 23, 2016
Should Epinephrine Autoinjectors Be Prescribed to All Patients on Subcutaneous Immunotherapy?David J Fitzhugh, David I Bernstein
The Journal of Allergy and Clinical Immunology. in Practice|January 10, 2018
On the Road to Improving Asthma Outcomes in Older Adults: The Phenotyping of Asthma in Older AdultsSameer K Mathur, David I Bernstein
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 20, 2007
Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroidsDavid I Bernstein, David B Allen
Current Allergy and Asthma Reports|April 29, 2010
Occupational rhinitisJ Wesley Sublett, David I Bernstein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2008
Rotarix: a rotavirus vaccine for the worldRichard L Ward, David I Bernstein
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 25, 2003
Key pollen allergens in North AmericaJason F White, David I Bernstein
Current Opinion in Obstetrics & Gynecology|September 6, 2005
Human papillomavirus vaccines and adolescentsJessica A Kahn, David I Bernstein
The Journal of Allergy and Clinical Immunology|January 25, 2022
Managing risk of anaphylaxis in patients receiving allergen immunotherapy: Assessing benefit versus riskDavid I Bernstein, Tolly G Epstein
Pageof 38

Showing results (41-50 of 379) with videos related to

Sort By:
Pageof 38
JAMA|May 2, 2013
HPV vaccination: too soon for 2 doses?Jessica A Kahn, David I Bernstein
Allergy and Asthma Proceedings|July 12, 2022
Safety of subcutaneous allergen immunotherapyDavid I Bernstein, Tolly G Epstein
The Journal of Allergy and Clinical Immunology. in Practice|May 23, 2016
Should Epinephrine Autoinjectors Be Prescribed to All Patients on Subcutaneous Immunotherapy?David J Fitzhugh, David I Bernstein
The Journal of Allergy and Clinical Immunology. in Practice|January 10, 2018
On the Road to Improving Asthma Outcomes in Older Adults: The Phenotyping of Asthma in Older AdultsSameer K Mathur, David I Bernstein
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 20, 2007
Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroidsDavid I Bernstein, David B Allen
Current Allergy and Asthma Reports|April 29, 2010
Occupational rhinitisJ Wesley Sublett, David I Bernstein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2008
Rotarix: a rotavirus vaccine for the worldRichard L Ward, David I Bernstein
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 25, 2003
Key pollen allergens in North AmericaJason F White, David I Bernstein
Current Opinion in Obstetrics & Gynecology|September 6, 2005
Human papillomavirus vaccines and adolescentsJessica A Kahn, David I Bernstein
The Journal of Allergy and Clinical Immunology|January 25, 2022
Managing risk of anaphylaxis in patients receiving allergen immunotherapy: Assessing benefit versus riskDavid I Bernstein, Tolly G Epstein
Pageof 38